Published in Microbes Infect on September 16, 2014
Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells. Stem Cell Res Ther (2016) 0.86
Developments in the management of Chagas cardiomyopathy. Expert Rev Cardiovasc Ther (2015) 0.85
Adipose Tissue-Derived Mesenchymal Stromal Cells Protect Mice Infected with Trypanosoma cruzi from Cardiac Damage through Modulation of Anti-parasite Immunity. PLoS Negl Trop Dis (2015) 0.77
Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations. Int J Nanomedicine (2017) 0.76
Stem Cell-Based Therapies in Chagasic Cardiomyopathy. Biomed Res Int (2015) 0.76
Internal associations and dynamic expression of c-kit and nanog genes in ventricular remodelling induced by adriamycin. Exp Ther Med (2016) 0.75
Galectin-3 Knockdown Impairs Survival, Migration, and Immunomodulatory Actions of Mesenchymal Stromal Cells in a Mouse Model of Chagas Disease Cardiomyopathy. Stem Cells Int (2017) 0.75
Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs. Mol Ther (2017) 0.75
Heart regeneration. Nature (2011) 5.91
CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol (2004) 4.08
Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A (2005) 3.93
Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science (2000) 3.75
Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells. Cell Cycle (2011) 3.49
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 3.33
Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop (2009) 3.22
Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation (2007) 2.99
WHO comparative evaluation of serologic assays for Chagas disease. Transfusion (2009) 2.80
The challenges of Chagas Disease-- grim outlook or glimmer of hope. PLoS Med (2007) 2.79
Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation (2003) 2.75
Chagas' disease. Clin Microbiol Rev (1992) 2.30
VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res (2011) 2.30
Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol (2001) 2.16
Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol (2000) 1.66
Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis (2009) 1.60
Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol (1999) 1.49
Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol (2005) 1.49
Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am J Trop Med Hyg (2006) 1.47
Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica (2007) 1.44
Chagas disease 101. Nature (2010) 1.43
Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev (2011) 1.37
Chagas disease has now gone global. PLoS Negl Trop Dis (2011) 1.34
Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? Bone Marrow Transplant (2011) 1.33
Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am J Pathol (2004) 1.32
Chagas heart disease pathogenesis: one mechanism or many? Curr Mol Med (2008) 1.26
Mesenchymal stem cell therapy for cardiac repair. Methods Mol Biol (2010) 1.26
In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol (2011) 1.22
Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging. J Nanobiotechnology (2011) 1.19
American trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategies. BMJ (2003) 1.16
Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model. J Infect Dis (2008) 1.16
Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation (2006) 1.15
Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem Inst Oswaldo Cruz (2009) 1.14
Chagas heart disease: report on recent developments. Cardiol Rev (2012) 1.02
Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int J Parasitol (2002) 0.99
Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial. Circulation (2012) 0.98
Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy. Int J Cardiol (2007) 0.97
In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy (2009) 0.96
Magnetic resonance imaging in experimental Chagas disease: a brief review of the utility of the method for monitoring right ventricular chamber dilatation. Parasitol Res (2005) 0.96
Mesenchymal bone marrow cell therapy in a mouse model of chagas disease. Where do the cells go? PLoS Negl Trop Dis (2012) 0.93
Labeling stem cells with superparamagnetic iron oxide nanoparticles: analysis of the labeling efficacy by microscopy and magnetic resonance imaging. Methods Mol Biol (2012) 0.91
In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label. Mol Imaging (2010) 0.91
Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease. Stem Cell Res (2012) 0.90
Biodistribution of bone marrow mononuclear cells in chronic chagasic cardiomyopathy after intracoronary injection. Int J Cardiol (2010) 0.89
Micro-positron emission tomography in the evaluation of Trypanosoma cruzi-induced heart disease: Comparison with other modalities. Am J Trop Med Hyg (2009) 0.89
In vivo Tracking of Transplanted Bone Marrow-Derived Mesenchymal Stem Cells in a Murine Model of Stroke by Bioluminescence Imaging. J Korean Neurosurg Soc (2010) 0.87
Gap junctions and chagas disease. Adv Parasitol (2011) 0.84
Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine. Heart Fail Rev (2012) 0.82
Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI. Am J Physiol Heart Circ Physiol (2010) 0.82
Cardioprotective actions of verapamil on the beta-adrenergic receptor complex in acute canine Chagas' disease. J Mol Cell Cardiol (1996) 0.80
Detection of matrix metallopeptidase-9-like proteins in Trypanosoma cruzi. Exp Parasitol (2010) 0.78